These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29474867)

  • 21. Impact of surface tension in pharmaceutical sciences.
    Fathi Azarbayjani A; Jouyban A; Chan SY
    J Pharm Pharm Sci; 2009; 12(2):218-28. PubMed ID: 19732499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of pH-dependent aqueous solubility of druglike molecules.
    Hansen NT; Kouskoumvekaki I; Jørgensen FS; Brunak S; Jónsdóttir SO
    J Chem Inf Model; 2006; 46(6):2601-9. PubMed ID: 17125200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals.
    Pasquali I; Bettini R; Giordano F
    Adv Drug Deliv Rev; 2008 Feb; 60(3):399-410. PubMed ID: 17964684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in intravenous delivery of poorly water-soluble compounds.
    Shi Y; Porter W; Merdan T; Li LC
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APPLICATION OF VARIOUS POLYMERS AND POLYMERS BASED TECHNIQUES USED TO IMPROVE SOLUBILITY OF POORLY WATER SOLUBLE DRUGS: A REVIEW.
    Muhammad Sarfraz R; Bashir S; Mahmood A; Ahsan H; Riaz H; Raza H; Rashid Z; Atif Raza S; Asad Abrar M; Abbas K; Yasmeen T
    Acta Pol Pharm; 2017 Mar; 74(2):347-356. PubMed ID: 29624239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-based systems for the enhanced delivery of poorly water soluble drugs.
    Porter CJ; Wasan KM; Constantinides P
    Adv Drug Deliv Rev; 2008 Mar; 60(6):615-6. PubMed ID: 18160174
    [No Abstract]   [Full Text] [Related]  

  • 27. Hot-melt extrusion.
    Jana S; Miloslava R
    Ceska Slov Farm; 2012 Jun; 61(3):87-92. PubMed ID: 22913823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticles: A personal experience for formulating poorly water soluble drugs.
    Cooper ER
    J Control Release; 2010 Feb; 141(3):300-2. PubMed ID: 19822177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aqueous solubility: simple predictive methods (in silico, in vitro and bio-relevant approaches).
    Elder D; Holm R
    Int J Pharm; 2013 Aug; 453(1):3-11. PubMed ID: 23124107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-line ATR-UV and Raman Spectroscopy for Monitoring API Dissolution Process During Liquid-Filled Soft-Gelatin Capsule Manufacturing.
    Wan B; Zordan CA; Lu X; McGeorge G
    AAPS PharmSciTech; 2016 Oct; 17(5):1173-81. PubMed ID: 26604007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proceedings of the 15th International Symposium on Pharmaceutical and Biomedical Analysis. May 2-6, 2004. Florence, Italy.
    J Pharm Biomed Anal; 2005 Apr; 37(5):829-1183. PubMed ID: 15862655
    [No Abstract]   [Full Text] [Related]  

  • 32. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting optimal wet granulation parameters for extrusion-spheronisation of pharmaceutical pellets using a mixer torque rheometer.
    Kuhs M; Moore J; Kollamaram G; Walker G; Croker D
    Int J Pharm; 2017 Jan; 517(1-2):19-24. PubMed ID: 27915006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug nanocrystals in the commercial pharmaceutical development process.
    Möschwitzer JP
    Int J Pharm; 2013 Aug; 453(1):142-56. PubMed ID: 23000841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NMR investigation of a novel excipient, α-glucosylhesperidin, as a suitable solubilizing agent for poorly water-soluble drugs.
    Zhang J; Tozuka Y; Uchiyama H; Higashi K; Moribe K; Takeuchi H; Yamamoto K
    J Pharm Sci; 2011 Oct; 100(10):4421-31. PubMed ID: 21604275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theme issue "Solid state and solid dosage forms".
    Kleinebudde P
    Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
    [No Abstract]   [Full Text] [Related]  

  • 38. [Progress in the research of amorphous pharmaceuticals].
    Ying J; Lü Y; Du GH
    Yao Xue Xue Bao; 2009 May; 44(5):443-8. PubMed ID: 19618716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation.
    Sauzet C; Claeys-Bruno M; Nicolas M; Kister J; Piccerelle P; Prinderre P
    Int J Pharm; 2009 Aug; 378(1-2):23-9. PubMed ID: 19465095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of salt screening methodologies.
    Fernández Casares A; Nap WM; Ten Figás G; Huizenga P; Groot R; Hoffmann M
    J Pharm Pharmacol; 2015 Jun; 67(6):812-22. PubMed ID: 25683791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.